Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Lung Neoplasms 5Prostatic Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Melanoma 3Leukemia 3Glioblastoma 3Cholangiocarcinoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Gliosarcoma 2Glioma 2Congenital Abnormalities 2Colonic Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomatitis 1Primary Myelofibrosis 1Polycythemia Vera 1Pleural Effusion, Malignant 1Pain 1

Interventions

hydrated silica gel-based toothpaste 1cobiprostone 1clazakizumab 1aluminum hydroxide, magnesium hydroxide, drug combination 1Zinc Sulfate 1Zinc 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Standard of Care 1Spectrometry, Fluorescence 1Sodium Bicarbonate 1Saliva, Artificial 1Saline Solution 1Radiation 1Mannitol 1Lidocaine 1Etanercept 1Drug Therapy 1Diphenhydramine 1Dental Prophylaxis 1Biotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Stomatitis × Drug Therapy × Clear all
NCT02542215 2019-12-02

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Mallinckrodt

Phase 2 Terminated
47 enrolled

Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡